Received Apr 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
| HEPA | HEP A (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
Incomplete Series; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete dose administered in a female patient who received Hepatitis A vaccine for prophylaxis. Co-suspect products included Hepatitis B vaccine for prophylaxis. On an unknown date, the patient received Hepatitis A vaccine and Hepatitis B vaccine. On an unknown date, an unknown time after receiving Hepatitis A vaccine and Hepatitis B vaccine, the patient experienced incomplete dose administered (Verbatim: Incomplete Series). The outcome of the incomplete dose administered was not applicable. Additional Information: GSK Receipt Date: 10-APR-2025 The pharmacist stated that a patient had received random doses of Hepatitis A and Hepatitis B in the early 90s but had not completed either series, which led to Incomplete dose administered.